Interior Health says it is making progress following up with Revelstoke residents who received one of 516 invalid COVID-19 vaccine doses.
The invalid doses were announced on Aug. 24. At the time, Interior Health said the vaccine doses had not been properly refrigerated, rendering them ‘invalid.’
Read our story from Aug. 24 on the 516 invalid doses administered in Revelstoke here:
In a Sept. 3 email response to our inquiry, Interior Health (IH) said it had called all 516 people affected by the invalid doses. “For anyone we had to leave a message for or did not have an answering machine, we are mailing letters to their home addresses,” IH said in its response.
IH said that it won’t know until they received an internal report on September 7 how many of those affected have rescheduled their appointments. However, IH said that “anecdotally” it has heard that residents affected have been scheduling new appointments.
Invalid doses were all Pfizer-BioNTech brand
In Revelstoke, to the best of our knowledge, COVID-19 vaccine doses administered to the public have been either the Moderna or Pfizer brands. Some residents received two doses of one brand, while others received one dose of each depending on availability on clinic days.
The Pfizer COVID-19 vaccine has strict and specific refrigeration requirements and is frozen at very cold temperatures. It is shipped in specially designed, temperature-controlled thermal shippers utilizing dry ice that keeps the vaccines at -70°C±10°C for up to 10 days unopened, according to an information release by Pfizer. The information release also spells out other specific refrigeration requirements and processes, and notes the vaccines are tracked using, “GPS-enabled thermal sensors with a control tower that will track the location and temperature of each vaccine shipment.”
The invalid doses were administered between July 9-30, 2021, but Interior Health stressed that only a portion of doses delivered during that period were invalid.
When the issue was announced on Aug. 24, Interior Health said receiving the invalid dose does not pose a health risk to those affected, that nobody who received invalid doses has been diagnosed with COVID-19, and that although they are deemed invalid, the doses may have nevertheless provided protection.